Surgical management after neoadjuvant imatinib therapy in gastrointestinal stromal tumours (GISTs) with respect to imatinib resistance caused by secondary KIT mutations.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples